Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: A report from the InterLymph Consortium
Rothman N Skibola CF Wang SS et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: A report from the InterLymph Consortium Lancet Oncol 7 2005 27-38
Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: Relevance to disease
Abraham LJ Kroeger KM Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: Relevance to disease J Leukoc Biol 66 1999 562-566
Allele-specific binding to the -308 single nucleotide polymorphism site in the tumour necrosis factor-alpha promoter
Baseggio L Bartholin L Chantome A et al. Allele-specific binding to the -308 single nucleotide polymorphism site in the tumour necrosis factor-alpha promoter Eur J Immunogenet 31 2004 15-19
In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading
Knight JC Keating BJ Rockett KA Kwiatkowski DP In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading Nat Genet 33 2003 469-475
Transcription of the IL10 gene reveals allele-specific regulation at the mRNA level
Kurreeman FA Schonkeren JJ Heijmans BT et al. Transcription of the IL10 gene reveals allele-specific regulation at the mRNA level Hum Mol Genet 13 2004 1755-1762
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
Rosenwald AG Wright W Chan J et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma N Engl J Med 346 2002 1937-1947
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response
Monti S Savage KJ Kutok JL et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response Blood 105 2005 1851-1861